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Background
Fed-batch cultivation is currently the most prominent
process for the production of Biologics using mamma-
lian cell lines such as CHO cells. Performance of fed-
batch processes greatly depends on the feeding strategy.
One important aspect of feeds is the nutrient concentra-
tion, which should be as high as possible. However, for
some nutrients, there are solubility and/or stability lim-
itations in aqueous solution. Thus, alternative systems
for liquid feed manufacturing were considered. Deep
Eutectic Solvents (DES) are salts in liquid state with a
melting point under 100°C in the absence of water that
form a eutectic system with a lower melting point than
either of the individual components. The result is a
highly concentrated, water free liquid system. A com-
mon component of DES is choline chloride (ChCl), a
quaternary ammonium salt. For cell culture applications,
ChCl is particularly well suited, since it is already widely
used as cell culture medium component. We have
experimentally manufactured deep eutectic solvents
(DES) for application as cell culture feeds containing
tyrosine and cysteine, which are challenging due to their
weak solubility and/or stability in aqueous solution.
Results
Various DES solutions were manufactured, which
showed very different characteristics in terms of concen-
trations, pH, stability and viscosity. The precise mechan-
isms of DES formation and the underlying principles are
poorly understood, making predictions of the DES prop-
erties very difficult. In general, the studied DES were
highly viscous fluids. One of the manufactured Cys-
ChCl DES was stable for 6 months. The following table
(Table 1) shows the concentrations of cysteine and tyro-
sine in selected DES compared to a typical aqueous
Cys/Tyr stock solution. The DES systems, including
only crystal water, allows for dramatic increases in feed
concentrations.
In a preliminary experiment for testing DES as cell
culture feed, fed-batch cultivations were carried out
comparing DES and a typical Cys/Tyr stock solution for
Cys/Tyr addition. Figure 1 shows the results in terms of
viable cell density (VCD) and viability. Viable Cell Den-
sity in DES fed cultures was slightly lower on day 10.
Osmolality was slightly higher for the DES approach, as
can be expected for addition of higher concentrated
feeds (data not shown). Absolute mAb concentration
was slightly lower due to lower VCD, but specific pro-
ductivity was about similar (data not shown).
Conclusions
We have successfully manufactured DES for use as cell
culture feeds. L-cysteine hydrochloride monohydrate
(L-Cys HCl H2O) and L-tyrosine hydrochloride (L-Tyr
HCl) were used to form two DES with Choline Chloride.
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Table 1 Concentrations of pure cysteine and tyrosine in





CHO Cys/Tyr stock solution 3.2 9.14
DES (ChCl + L-Cys HCl H2O, 1:1) 38.99 -
DES (ChCl + H2O + L-Tyr, 3:3:1) - 26.21
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A range of temperatures and substance ratios to form a
stable DES were tested.
Subsequently, the DES feeds were compared in a cell
culture fed-batch process using a typical Cyr/Tyr CHO
feed for comparison. Our preliminary results suggest
that DES could be used as alternative cell culture feeds
in the future. Possible advantages of such a strategy
would be lower feed volumes required due to ultra-high
feed concentration, no extra water (expect hydrate)
diluting the content and thus less volume increase in
bioreactors and improved bioreactor utilization.
However, there are many open points to study. It
would be preferable to use one DES feed including both
Cys/Tyr, but such a system showed to be far more com-
plex to manufacture. Stability and bioavailability need to
be studied in detail. Tests with additional cell lines, dif-
ferent feeding regimes etc. are ongoing. Even if these
points can be clarified, it would be advisable to develop
a completely new feeding strategy for DES to increase
the performance with these feeds.
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Figure 1 Viable cell density and Viability during fed-batch
cultivation of CHO cells using DES feeds compared to a typical
aqueous Cys/Tyr feed solution.
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